Search Results - "Kimmick, Gretchen Genevieve"

The real-world modeling of benefits demonstrated in major clinical trials on 2 HR+/HER2− metastatic breast cancer treatment with CDK4/6 inhibitor in the US: PALOMA-2 and MONALEESA-3 by Pilehvari, Asal, Kimmick, Gretchen Genevieve, You, Wen, Bonilla, Gloribel, Anderson, Roger T

“…e13070 Background: This retrospective study addresses the question of whether real-world treatment with CDK4/6 inhibitors in combination with Endocrine Therapy…”
Get full text

Survival among patients with untreated metastatic breast cancer by Plichta, Jennifer Kay, Thomas, Samantha M., Sammons, Sarah, McDuff, Susan G.R., DiLalla, Gayle, Kimmick, Gretchen Genevieve, Hwang, Eun-Sil Shelley

“…Abstract only 1095 Background: Treatments for metastatic breast cancer (MBC) have significantly improved survival for patients who receive treatment, yet data…”
Get full text

Molecular profiling of serial liquid biopsy specimens utilizing cell free DNA (cfDNA) and circulating tumor cells (CTCs) in TBCRC041: A phase II study of alisertib in endocrine resistant metastatic breast cancer (MBC) by Giridhar, Karthik, Suman, Vera Jean, Tang, Xiaojia, Ye, Hong, Campbell, Jordan, Mayer, Erica L., Karuturi, Meghan Sri, Morikawa, Aki, Kimmick, Gretchen Genevieve, Isaacs, Claudine, Young Oh, Sun, Clark, Amy Sanders, Park, Ben Ho, Bucheit, Leslie A, Tsai, Jill, Ingle, James N., Goetz, Matthew P., D'assoro, Antonino Bonaventura, Kalari, Krishna Rani, Haddad, Tufia C.

“…1037 Background: TBCRC041, a randomized phase 2 trial of alisertib (A) ± fulvestrant (F) in women with HR+/HER2- MBC demonstrated promising clinical activity…”
Get full text

Feasibility intervention to increase exercise outcome expectations among breast cancer survivors by Hirschey, Rachel, Pan, Wei, Kimmick, Gretchen Genevieve, Hockenberry, Marilyn, Shaw, Ryan, Lipkus, Isaac

“…Abstract only e21584 Background: Exercise is associated with decreased mortality and recurrence risk and improved quality of life for breast cancer survivors…”
Get full text

Restaging de novo metastatic breast cancer to refine prognostic estimates by Plichta, Jennifer Kay, Thomas, Samantha M., Sergesketter, Amanda R, Fayanju, Oluwadamilola Motunrayo, Greenup, Rachel Adams, Rosenberger, Laura Horst, Kimmick, Gretchen Genevieve, Hyslop, Terry, Hwang, Eun-Sil Shelley

“…Abstract only…”
Get full text

Using a geriatric oncology assessment to link with services in an underserved, community oncology population by Zullig, Leah L., Kimmick, Gretchen Genevieve, Smith, Valerie, Little, Katie, Bosworth, Hayden B, Gonzales, Sarah, Oakes, Megan, Shelby, Rebecca A., Owen, Lynda, Sutton, Linda, Altomare, Ivy

“…Abstract only…”
Get full text

Androgen deprivation therapy (ADT) and cardiovascular mortality (CVD) in men with early-stage prostate cancer (PC) receiving curative radiation therapy (RT) by Hanlon, Ashley, Fleming, Steven, Hamilton, Ann S, Dinan, Michaela Ann, Melloni, Chiara, Harrison, Michael Roger, Khouri, Michel, Wu, Xiao-cheng, Wilson, J. Frank, Lipscomb, Joseph, Cress, Rosemary Donaldson, Anderson, Roger T, Kimmick, Gretchen Genevieve

“…Abstract only 127 Background: Combined with RT, ADT is a highly effective and utilized treatment for men with localized PC, but some studies suggest that use…”
Get full text

Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy (AET) by Kimmick, Gretchen Genevieve, Bosworth, Hayden B, Keefe, Francis J, Sutton, Linda, Owen, Lynda, Erkanli, Alaattin, Reed, Shelby D., Staley, Sarah A, Pak, Sarah, Barrett, Nadine, Huettel, Scott, Shelby, Rebecca A.

“…Abstract only TPS10128 Background: Adjuvant endocrine therapy (AET) is a crucial component of treatment used to prevent recurrence and reduce mortality for…”
Get full text

Immune profiling of BRCA-mutated breast cancers by Force, Jeremy Meyer, Abbott, Sarah, Broadwater, Gloria, Stashko, Ilona, Westbrook, Kelly E., Kimmick, Gretchen Genevieve, Sammons, Sarah LeNoir, Hyslop, Terry, Brauer, Heather Ann, Mashadi-Hossein, Afshin, Plichta, Jennifer Kay, Hwang, Eun-Sil Shelley, Kauff, Noah D., Weinhold, Kent J., Nair, Smita, Castellar, Edgardo, Marcom, Paul Kelly

“…Abstract only…”
Get full text

Patient(Pt)-reported toxicities during breast cancer (BC) chemotherapy (CRx): Associations with pre-treatment (Tx) measures of quality of life (QOL) and Tx discontinuation by Nyrop, Kirsten A., Deal, Allison Mary, Shachar, Shlomit S., Basch, Ethan M., Reeve, Bryce B., Lee, Jordan T, Choi, Seul Ki, Wood, William Allen, Anders, Carey K., Carey, Lisa A., Dees, Elizabeth Claire, Jolly, Trevor Augustus, Reeder-Hayes, Katherine Elizabeth, Kimmick, Gretchen Genevieve, Karuturi, Meghan Sri, Reinbolt, Raquel E., Speca, Joellen C., Muss, Hyman B.

“…Abstract only…”
Get full text

Patient(Pt)-reported toxicities by chemotherapy regimen for early breast cancer (BC) (LCCC1334/1440) by Nyrop, Kirsten A., Deal, Allison Mary, Shachar, Shlomit S., Basch, Ethan M., Reeve, Bryce B., Lee, Jordan T, Choi, Seul Ki, Wood, William Allen, Anders, Carey K., Carey, Lisa A., Dees, Elizabeth Claire, Jolly, Trevor Augustus, Reeder-Hayes, Katherine Elizabeth, Kimmick, Gretchen Genevieve, Karuturi, Meghan Sri, Reinbolt, Raquel E., Speca, Joellen C., Muss, Hyman B.

“…Abstract only…”
Get full text

Patient experiences and preferences for survivorship care by Mitchell, Kelly Westbrook, Houck, Kevin, Kimmick, Gretchen Genevieve, Trotter, Kathy J., Peppercorn, Jeffrey M.

“…Abstract only 110 Background: The optimal method for delivery of care to over 2 million breast cancer survivors in the U.S. remains unclear, with multiple…”
Get full text

Disparities in breast cancer presentation and treatment of older women, by insurance status by Ursem, Carling, Kimmick, Gretchen Genevieve, Anderson, Roger T., Hwang, Wenke, Camacho, Fabian

“…Abstract only e17516 Background: Disparities are known to exist in breast cancer outcomes by age and socioeconomic status (SES), but there is little data…”
Get full text

Effect of alphavirus vaccine encoding HER2 during concurrent anti-HER2 therapies on induction of oligoclonal T cell and antibody responses against HER2 by Gwin, William Rayford, Hobeika, Amy, Osada, Takuya, Hartman, Zachary, Cheng, Qing, Broadwater, Gloria, Kimmick, Gretchen Genevieve, Blackwell, Kimberly L., Morse, Michael, Lyerly, Kim

“…Abstract only…”
Get full text

Grip strength and timed get-up-and-go: Associations with symptoms among women taking adjuvant endocrine therapy by Sitlinger, Andrea Phillips, Shelby, Rebecca A., White, Heidi K, Edmond, Sara N., Bosworth, Hayden B, Keefe, Francis J, Kimmick, Gretchen Genevieve

“…Abstract only…”
Get full text

Increased FoxP3 and PD-L1 in non-pCR tissue from early stage HER2 positive breast cancer patients treated with trastuzumab-pertuzumab based regimens by Force, Jeremy Meyer, Howie, Lynn Jackson, Abbott, Sara, Bentley, Rex C., Marcom, Paul K., Kimmick, Gretchen Genevieve, Westbrook, Kelly E., Parks, Michelle, Topping, Donna L., Broadwater, Gloria, Blackwell, Kimberly L., Nair, Smita K

“…Abstract only…”
Get full text

Accrual of older patients (pts) with breast cancer to Alliance systemic therapy trials over time: A151527 by Freedman, Rachel A., Seisler, Drew K., Foster, Jared C., Lafky, Jacqueline M., Kimmick, Gretchen Genevieve, Jatoi, Aminah, Muss, Hyman B., Cohen, Harvey Jay, Mandelblatt, Jeanne S., Winer, Eric P., Hudis, Clifford A., Cirrincione, Constance T., Moreno-Aspitia, Alvaro, Hurria, Arti

“…Abstract only…”
Get full text

Patient experience and attitudes toward addressing the cost of breast cancer care by Irwin, Blair Billings, Zafar, Yousuf, Altomare, Ivy, Kimmick, Gretchen Genevieve, Marcom, P. Kelly, Houck, Kevin, Peppercorn, Jeffrey M.

“…Abstract only 6551 Background: The American Society of Clinical Oncology has suggested that patient-physician discussion of costs is a component of high…”
Get full text

Obesity and guideline-concordant systemic therapy for locoregional breast cancer by Moore, Hollis, Trentham-Dietz, Amy, Greenberg, Caprice Christian, Vanness, David J., Hampton, John M, Wu, Xiao-cheng, Anderson, Roger T., Lipscomb, Joseph, Kimmick, Gretchen Genevieve, Cress, Rosemary Donaldson, Fleming, Steven, Wilson, J. Frank

“…Abstract only 145 Background: Obese breast cancer patients tend to have higher mortality than non-obese patients. Hypothesizing that differences in receipt of…”
Get full text

Clinical impact of febrile neutropenia (FN) increase among patients receiving adjuvant docetaxel/cyclophosphamide (TC) chemotherapy compared to TC plus pegfilgrastim for breast cancer by Hamilton, Erika Paige, Topping, Donna L., Peppercorn, Jeffrey M., Marcom, P. Kelly, Kimmick, Gretchen Genevieve, Duff, Erin, Cirrincione, Constance T., Blackwell, Kimberly L.

“…Abstract only 1076 Background: The FN rate for the approved regimen of TC is 5% in pivotal studies. Other small retrospective reports have reported FN rates as…”
Get full text